Columbia Laboratories, Inc. (CBRX) Narrows Q4 Loss by 5c/Share; Revs Lighten

Columbia Laboratories, Inc. (NASDAQ: CBRX) reported Q4 EPS of ($0.01), versus ($0.06) reported last year. Revenue for the quarter came in at $6.4 million, versus $14.9 million reported last year.

For earnings history and earnings-related data on Columbia Laboratories, Inc. (CBRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Evaxion adds brain cancer vaccine program, drops EVX-03
• Bonk, Inc. posts $5.5M revenue in H1 2026, reports $7.88M net loss